Advancells
Advancells is a Noida, India-based life sciences supplier founded in 2013 that provides high-quality primary cells, including stem cells, to research institutions and to customers addressing lifestyle disorders.
- Company typePrivate
- Founded2013
- HeadquartersNoida, India
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Advancells does
Advancells is a Noida, India-based for-profit company founded in 2013 that supplies high-quality primary cells, including stem cells, for use in research studies and for lifestyle disorder applications. The company operates as a life sciences consumables provider, serving institutional research buyers (academic and biopharma) and potentially clinical or consumer-facing customers interested in stem cell-based approaches to lifestyle disorders. Core product scope is biological rather than computational, and the input does not disclose proprietary process technology, patents, or certifications that would substantiate defensible technical differentiation.
The company's operating footprint is small, with a headcount in the 11-50 range and a single identifiable leadership position (Meenu Jain, Director). The input material does not disclose revenue, pricing, customer concentration, funding history, certifications, partnerships, or product-level technical specifications. The official website returned a verification/loader page during data collection, limiting extractable first-party detail. As a result, the business model mechanics, go-to-market motion, and unit economics cannot be characterized beyond the core supply-side function of providing primary and stem cell products to research and lifestyle-disorder customers.
For an investment audience, the central data gap is the absence of disclosed financials, customer logos, and regulatory/certification posture (e.g., ISO, GMP, CDSCO licensing) that are standard due diligence checkpoints for a cell-based life sciences supplier. The 2013 vintage and sub-50 headcount suggest a boutique, slow-scale profile rather than a venture-backed growth company, but this cannot be confirmed without additional primary data.
Advancells firmographics
Firmographics- Name
- Advancells
- Website
- https://advancells.com
- Company type
- Private
- Founded year
- 2013
- Headcount range
- 11–50 employees
- Short description
- Advancells is a Noida, India-based life sciences supplier founded in 2013 that provides high-quality primary cells, including stem cells, to research institutions and to customers addressing lifestyle disorders.
- Ownership category
- akta.pro rank
Advancells industry classification
Industry- Product category
- Regenerative Medicine / Cell Therapy
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
- akta.pro secondary industries
- Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)
Keywords
Where Advancells is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Markets served
Advancells business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Advancells product offering
Product offeringCore offering
Advancells provides high-quality primary cells, including stem cells, for use in research studies and for applications addressing lifestyle disorders. The company serves both research customers needing cell-based research inputs and end-users/clinical applications in regenerative medicine.
Differentiator
Problem solved
Functional benefit
Products and services
- Primary Cells (including Stem Cells) High-quality primary cells and stem cells supplied by Advancells for use in research studies and in addressing lifestyle disorders. Target users include research laboratories, academic institutions, and clinical/patient customers seeking cell-based inputs for scientific or therapeutic purposes.
Companies that use Advancells
Customer profileIdeal customer profiles2 records
Advancells technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Advancells partnerships and signals
Strategic signalExpansion highlights1 record
Advancells competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Global cell and gene therapy manufacturing services and primary cell supplier serving pharma and research customers; comparable as a primary cell supplier and cell therapy CDMO, though Lonza operates at a vastly larger scale across multiple geographies.
- Bio-Techne: Global supplier of research reagents including primary cells, stem cell products, and cell culture tools to life science researchers — overlaps with Advancells' research-customer segment of its primary cell/stem cell supply business.
- Stemcell Technologies: Large Canadian supplier of primary cells, stem cells, and cell culture reagents to research and therapy customers globally — directly comparable product portfolio to Advancells' primary cell / stem cell supply business, but at vastly greater scale and geographic reach.
- Thermo Fisher Scientific (Cell Therapy / Primary Cells): Through its bioscience and cell therapy businesses, Thermo Fisher offers primary cells, stem cell products, and cell therapy manufacturing services — a broad incumbent serving the same research and therapeutic cell markets as Advancells.
Direct peers
- CellGenix: Supplier of cell processing reagents, cytokines, and ancillary materials for cell and gene therapy developers — a directly comparable specialty cell therapy supply business, though with a stronger focus on therapy-grade manufacturing inputs.
- Mesoblast: Clinical-stage cell therapy developer using mesenchymal lineage stem cells to treat inflammatory and lifestyle-related diseases — comparable therapeutic focus area to Advancells' lifestyle-disorder applications.
Regional players
- HiMedia Laboratories: Indian life sciences supplier of cell culture media, sera, and related cell biology consumables — comparable as a domestic Indian peer in the cell culture / research supply category.
- Stempeutics Research: India-based stem cell company developing and commercializing regenerative medicine therapies — directly comparable as a domestic Indian peer operating in the stem cell therapy space with similar therapeutic ambitions.
- Regrow Biosciences: India-based cell therapy company developing autologous and allogeneic stem cell products for orthopedic and lifestyle indications — directly comparable as an Indian regional peer in the stem cell therapeutic space.
- Syngene International: India-based contract research and manufacturing services organization serving global biopharma — comparable as an Indian life sciences peer with R&D and cell biology capabilities, though operating at significantly larger scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Advancells social profiles
Digital presenceAdvancells financial estimates
Financial estimateRevenue estimate
Valuation estimate
Advancells leadership team
Management profileNumber of profiles
Profiles1 record
Advancells funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Advancells M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Advancells
What does Advancells do?
Advancells provides high-quality primary cells, including stem cells, for use in research studies and for applications addressing lifestyle disorders. The company serves both research customers needing cell-based research inputs and end-users/clinical applications in regenerative medicine.
When was Advancells founded?
Advancells was founded in 2013. It employs 11 to 50 people.
Where is Advancells based?
Advancells is headquartered in Noida, India, in the Asia region.
Who are Advancells's main competitors?
Broad incumbents on record are Lonza Group, Bio-Techne, Stemcell Technologies and Thermo Fisher Scientific (Cell Therapy / Primary Cells). Direct peers are CellGenix and Mesoblast. Regional players are HiMedia Laboratories, Stempeutics Research, Regrow Biosciences and Syngene International.
Does Advancells have an API?
No public API is recorded for Advancells.
What industry is Advancells in?
Advancells's product category is Regenerative Medicine / Cell Therapy. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAAAGAA, Stem Cell–Based Regenerative Therapies. Its NAICS code is 541714 and its SIC code is 8000.